[HTML][HTML] Hydrogen therapy and its future prospects for ameliorating COVID-19: clinical applications, efficacy, and modality

I Perveen, B Bukhari, M Najeeb, S Nazir, TA Faridi… - Biomedicines, 2023 - mdpi.com
Molecular hydrogen is renowned as an odorless and colorless gas. The recommendations
developed by China suggest that the inhalation of hydrogen molecules is currently advised …

[HTML][HTML] CC chemokine receptor 4 (CCR4) as a possible new target for therapy

J Bogacka, K Pawlik, K Ciapała… - International Journal of …, 2022 - mdpi.com
Chemokines and their receptors participate in many biological processes, including the
modulation of neuroimmune interactions. Approximately fifty chemokines are distinguished …

[HTML][HTML] Mechanistic insights into the role of the chemokine CCL2/CCR2 axis in dorsal root ganglia to peripheral inflammation and pain hypersensitivity

MA Dansereau, É Midavaine, V Bégin-Lavallée… - Journal of …, 2021 - Springer
Background Pain is reported as the leading cause of disability in the common forms of
inflammatory arthritis conditions. Acting as a key player in nociceptive processing …

The CCL2/CCL7/CCL12/CCR2 pathway is substantially and persistently upregulated in mice after traumatic brain injury, and CCL2 modulates the complement system …

K Popiolek-Barczyk, A Ciechanowska, K Ciapała… - Molecular and cellular …, 2020 - Elsevier
Traumatic brain injury (TBI) is the leading cause of death in the global population. Disturbed
inflammatory processes after TBI exacerbate secondary brain injury and contribute to …

Pharmacologic depletion of microglia increases viral load in the brain and enhances mortality in murine models of flavivirus-induced encephalitis

S Seitz, P Clarke, KL Tyler - Journal of Virology, 2018 - Am Soc Microbiol
Flaviviruses account for most arthropod-borne cases of human encephalitis in the world.
However, the exact mechanisms of injury to the central nervous system (CNS) during …

CXCL13/CXCR5 signaling contributes to diabetes-induced tactile allodynia via activating pERK, pSTAT3, pAKT pathways and pro-inflammatory cytokines production …

S Liu, X Liu, H Xiong, W Wang, Y Liu, L Yin, C Tu… - Brain, Behavior, and …, 2019 - Elsevier
Painful diabetic neuropathy (PDN) is a severely debilitating chronic pain syndrome. Spinal
chemokine CXCL13 and its receptor CXCR5 were recently demonstrated to play a pivotal …

[HTML][HTML] Neuropathic pain: biomolecular intervention and imaging via targeting microglia activation

A Ji, J Xu - Biomolecules, 2021 - mdpi.com
Many diseases, including cancer, can lead to neuropathic pain (NP). NP is one of the
accompanying symptoms of suffering in many conditions and the life quality of NP patient is …

[HTML][HTML] The RS504393 influences the level of nociceptive factors and enhances opioid analgesic potency in neuropathic rats

K Kwiatkowski, A Piotrowska, E Rojewska… - Journal of Neuroimmune …, 2017 - Springer
Increasing evidence has indicated that activated glial cells releasing nociceptive factors,
such as interleukins and chemokines, are of key importance for neuropathic pain. Significant …

[HTML][HTML] Targeting members of the chemokine family as a novel approach to treating neuropathic pain

K Pawlik, J Mika - Molecules, 2023 - mdpi.com
Neuropathic pain is a debilitating condition that affects millions of people worldwide.
Numerous studies indicate that this type of pain is a chronic condition with a complex …

[HTML][HTML] Bidirectional action of cenicriviroc, a CCR2/CCR5 antagonist, results in alleviation of pain-related behaviors and potentiation of opioid analgesia in rats with …

K Kwiatkowski, K Pawlik, K Ciapała… - Frontiers in …, 2020 - frontiersin.org
Clinical management of neuropathic pain is unsatisfactory, mainly due to its resistance to the
effects of available analgesics, including opioids. Converging evidence indicates the …